B
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Price:
59
HKD
-3.44%
Market Closed
Market Cap:
HK$23.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
|
CN |
|
Shanghai Zhenhua Heavy Industries Co Ltd
SSE:600320
|
CN |
|
B
|
BMW Industries Ltd
BSE:542669
|
IN |
Cash Flow Statement
Cash Flow Statement
Biocytogen Pharmaceuticals Beijing Co Ltd
Biocytogen Pharmaceuticals Beijing Co Ltd
Currency: CNY
| Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Net Income |
0
|
(380)
|
0
|
43
|
0
|
|
| Depreciation & Amortization |
0
|
182
|
0
|
169
|
0
|
|
| Stock-Based Compensation |
10
|
31
|
24
|
23
|
37
|
|
| Other Non-Cash Items |
0
|
131
|
0
|
140
|
0
|
|
| Cash Taxes Paid |
0
|
1
|
4
|
9
|
22
|
|
| Cash Interest Paid |
23
|
24
|
29
|
31
|
31
|
|
| Change in Working Capital |
(210)
|
(10)
|
(29)
|
(141)
|
385
|
|
| Cash from Operating Activities |
(210)
N/A
|
(77)
+63%
|
(29)
+62%
|
211
N/A
|
385
+82%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(194)
|
(127)
|
(59)
|
(37)
|
(46)
|
|
| Other Items |
(6)
|
26
|
17
|
(100)
|
(142)
|
|
| Cash from Investing Activities |
(201)
N/A
|
(100)
+50%
|
(42)
+58%
|
(137)
-225%
|
(188)
-37%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
(28)
|
(8)
|
0
|
(10)
|
(19)
|
|
| Net Issuance of Debt |
155
|
147
|
140
|
28
|
(22)
|
|
| Other |
469
|
(177)
|
(213)
|
(111)
|
(125)
|
|
| Cash from Financing Activities |
597
N/A
|
(38)
N/A
|
(73)
-92%
|
(92)
-26%
|
(166)
-80%
|
|
| Change in Cash | ||||||
| Effect of Foreign Exchange Rates |
17
|
3
|
(4)
|
3
|
4
|
|
| Net Change in Cash |
203
N/A
|
(211)
N/A
|
(149)
+30%
|
(15)
+90%
|
35
N/A
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(404)
N/A
|
(203)
+50%
|
(88)
+57%
|
174
N/A
|
339
+94%
|
|
Switch to:
Switch to:
See Also
Discover More
